Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Study of Systemic Chemotherapy With or Without HAI FUDR/Dexamethasone in Patients With Unresectable Intrahepatic Cholangiocarcinoma
Conditions
Interventions
Gemcitabine
Oxaliplatin
+3 more
Locations
11
United States
National Heart, Lung, and Blood Institute (NIH) (Data Collection Only)
Bethesda, Maryland, United States
Washington University (Data Collection Only)
St Louis, Missouri, United States
Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth - Limited Protocol Activities
Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen - Limited Protocol Activities
Montvale, New Jersey, United States
Memorial Sloan Kettering Commack - Limited Protocol Activities
Commack, New York, United States
Start Date
May 7, 2021
Primary Completion Date
May 1, 2027
Completion Date
May 1, 2027
Last Updated
April 22, 2026
NCT06313203
NCT07337850
NCT06925516
NCT06406816
NCT06956716
NCT05342194
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions